ZA823980B - 5-asa drug delivery system - Google Patents
5-asa drug delivery systemInfo
- Publication number
- ZA823980B ZA823980B ZA823980A ZA823980A ZA823980B ZA 823980 B ZA823980 B ZA 823980B ZA 823980 A ZA823980 A ZA 823980A ZA 823980 A ZA823980 A ZA 823980A ZA 823980 B ZA823980 B ZA 823980B
- Authority
- ZA
- South Africa
- Prior art keywords
- delivery system
- drug delivery
- asa drug
- asa
- drug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/271,748 US4374932A (en) | 1981-06-08 | 1981-06-08 | 5-ASA Drug delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA823980B true ZA823980B (en) | 1983-07-27 |
Family
ID=23036907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA823980A ZA823980B (en) | 1981-06-08 | 1982-06-07 | 5-asa drug delivery system |
Country Status (13)
Country | Link |
---|---|
US (1) | US4374932A (fr) |
EP (1) | EP0066861B1 (fr) |
JP (1) | JPS57212119A (fr) |
AU (1) | AU8462282A (fr) |
CA (1) | CA1200204A (fr) |
DE (1) | DE3262768D1 (fr) |
DK (1) | DK253782A (fr) |
ES (1) | ES512897A0 (fr) |
IE (1) | IE53518B1 (fr) |
NO (1) | NO153396C (fr) |
NZ (1) | NZ200882A (fr) |
PT (1) | PT75021B (fr) |
ZA (1) | ZA823980B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57500432A (fr) * | 1980-03-20 | 1982-03-11 | ||
US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
SE8405924L (sv) * | 1984-11-23 | 1986-05-24 | Pharmacia Ab | Nya azoforeningar |
CA2122717C (fr) * | 1991-11-08 | 2003-07-15 | David C. Anderson | Hemoglobines utilisees comme agents d'administration de medicaments |
US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
DE60140491D1 (de) | 2000-08-29 | 2009-12-24 | Biocon Ltd | Verwendung einer pharmazeutischen Zusammensetzung mit einem Para-Aminophenylessigsäurederivat für die Behandlung von entzündlichen Erkrankungen des Magen-Darmtrakts |
US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
EP1429728A1 (fr) * | 2001-08-29 | 2004-06-23 | SRL Technologies, Inc. | Preparations a liberation prolongee |
US7737133B2 (en) * | 2003-09-03 | 2010-06-15 | Agi Therapeutics Ltd. | Formulations and methods of treating inflammatory bowel disease |
US7825106B2 (en) | 2003-09-03 | 2010-11-02 | Agi Therapeutics Ltd. | Modified release formulations and methods of treating inflammatory bowel disease |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
DK1773767T3 (en) | 2004-07-07 | 2016-03-21 | Biocon Ltd | Synthesis of azo bound in immune regulatory relations |
US7541384B2 (en) | 2007-06-08 | 2009-06-02 | Axcan Pharma Inc. | Mesalamine suppository |
US8436051B2 (en) * | 2007-06-08 | 2013-05-07 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
US8217083B2 (en) * | 2007-06-08 | 2012-07-10 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
FR2986010A1 (fr) * | 2012-01-19 | 2013-07-26 | Biomerieux Sa | Detection in vitro de microorganismes presentant une activite azoreductase |
JP6564369B2 (ja) | 2013-12-09 | 2019-08-21 | デュレクト コーポレイション | 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法 |
CN108479727A (zh) * | 2018-03-20 | 2018-09-04 | 中山大学惠州研究院 | 一种水杨酸改性的苯乙烯聚合物及其吸附回收工业废水中苯胺类组分的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB408676A (en) * | 1931-10-17 | 1934-04-16 | Ig Farbenindustrie Ag | The manufacture of symmetrically substituted azobenzene compounds |
US2697059A (en) * | 1951-01-22 | 1954-12-14 | Edwin L Gustus | Hydroxy aromatic carboxylate-resin adsorption composition |
US2721827A (en) * | 1952-08-29 | 1955-10-25 | Edwin L Gustus | Composition containing polyamine resin having adsorbed thereon an anion of para-aminosalicylic acid |
US2990332A (en) * | 1958-04-02 | 1961-06-27 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith |
US3143465A (en) * | 1961-06-19 | 1964-08-04 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon; and treatment therewith |
SE7905051L (sv) * | 1979-06-11 | 1980-12-12 | Pharmacia Ab | Nya sulfonamider |
SE8002322L (sv) * | 1980-03-26 | 1981-09-27 | Pharmacia Ab | Medel for behandling av inflammatoriska tarmsjukdomar |
DE3027013A1 (de) * | 1980-07-17 | 1982-02-18 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin | Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln |
-
1981
- 1981-06-08 US US06/271,748 patent/US4374932A/en not_active Expired - Fee Related
-
1982
- 1982-06-04 EP EP82104921A patent/EP0066861B1/fr not_active Expired
- 1982-06-04 DE DE8282104921T patent/DE3262768D1/de not_active Expired
- 1982-06-04 DK DK253782A patent/DK253782A/da not_active Application Discontinuation
- 1982-06-07 ES ES512897A patent/ES512897A0/es active Granted
- 1982-06-07 JP JP57097485A patent/JPS57212119A/ja active Pending
- 1982-06-07 PT PT75021A patent/PT75021B/pt unknown
- 1982-06-07 NO NO821898A patent/NO153396C/no unknown
- 1982-06-07 CA CA000404608A patent/CA1200204A/fr not_active Expired
- 1982-06-07 AU AU84622/82A patent/AU8462282A/en not_active Abandoned
- 1982-06-07 ZA ZA823980A patent/ZA823980B/xx unknown
- 1982-06-08 IE IE1361/82A patent/IE53518B1/en unknown
- 1982-06-08 NZ NZ200882A patent/NZ200882A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES8304539A1 (es) | 1983-03-01 |
EP0066861B1 (fr) | 1985-03-27 |
US4374932A (en) | 1983-02-22 |
AU8462282A (en) | 1982-12-16 |
PT75021A (en) | 1982-07-01 |
IE821361L (en) | 1982-12-08 |
JPS57212119A (en) | 1982-12-27 |
DE3262768D1 (de) | 1985-05-02 |
NO821898L (no) | 1982-12-09 |
EP0066861A1 (fr) | 1982-12-15 |
NO153396B (no) | 1985-12-02 |
PT75021B (en) | 1984-01-04 |
NZ200882A (en) | 1985-08-30 |
NO153396C (no) | 1986-03-12 |
IE53518B1 (en) | 1988-12-07 |
CA1200204A (fr) | 1986-02-04 |
DK253782A (da) | 1982-12-09 |
ES512897A0 (es) | 1983-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8322007D0 (en) | Pharmaceutical delivery system | |
ZA82306B (en) | Sustained release delivery system | |
GB2140687B (en) | Osmotic drug delivery system | |
GB8519530D0 (en) | Drug delivery system | |
GB2100705B (en) | Monitored delivery systems | |
GB2166051B (en) | Colonic therapeutic delivery system | |
IL68159A0 (en) | Closed drug delivery system | |
GB2185397B (en) | Drug delivery system | |
DE3570594D1 (en) | Closed drug delivery system | |
ZA857355B (en) | Novel drug delivery system | |
GB8630273D0 (en) | Pharmaceutical delivery systems | |
ZA87737B (en) | Drug delivery system | |
DE3369468D1 (en) | Osmotic drug delivery system | |
HK10088A (en) | Inhalation pharmaceuticals | |
GB2105189B (en) | Inhalation drugs | |
ZA823980B (en) | 5-asa drug delivery system | |
GB2107191B (en) | Parenteral delivery system | |
GB2146525B (en) | Drug delivery system | |
GB2040687B (en) | Catheter delivery system | |
PH25638A (en) | Microparticle drug delivery system | |
EP0182502A3 (en) | Drug delivery system | |
JPS57150960A (en) | Delivery stand | |
ZA795549B (en) | Microparticle drug delivery system | |
JPS57125757A (en) | Drug dosing member | |
ZA824075B (en) | Pneumatic-tube conveying system |